Kreuter, M. (2013). Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: The TREAT study. Annals of oncology, 24(4), . https://doi.org/10.1093/annonc/mds578
Chicago Style (17th ed.) CitationKreuter, Michael. "Randomized Phase 2 Trial on Refinement of Early-stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed Versus Cisplatin and Vinorelbine: The TREAT Study." Annals of Oncology 24, no. 4 (2013). https://doi.org/10.1093/annonc/mds578.
MLA (9th ed.) CitationKreuter, Michael. "Randomized Phase 2 Trial on Refinement of Early-stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed Versus Cisplatin and Vinorelbine: The TREAT Study." Annals of Oncology, vol. 24, no. 4, 2013, https://doi.org/10.1093/annonc/mds578.